Related Experiment Videos
Lipid effects of antihypertensive drugs
1Oslo University Medical School, Department of Medicine, Ullevål Hospital, Norway.
Insights
Certain blood pressure medications, like diuretics and beta-blockers, negatively impact lipid levels. Other antihypertensives, including ACE-inhibitors and calcium channel blockers, are lipid neutral, while alpha-blockers may improve lipid profiles.
Area of Science:
- Cardiology
- Pharmacology
- Metabolic Research
Background:
- Coronary heart disease (CHD) is strongly linked to hypertension.
- Standard treatments for hypertension, such as diuretics and beta-adrenergic blockers, do not protect against CHD.
- This lack of protection may stem from adverse effects on lipid metabolism.
Purpose of the Study:
- To compare the effects of commonly prescribed antihypertensive drugs on lipid profiles.
- To identify antihypertensive medications with neutral or favorable impacts on lipid metabolism.
Main Methods:
- A literature survey of selected studies was conducted.
- The focus was on comparing the lipid profiles associated with various antihypertensive drug classes.
Main Results:
- Diuretics and beta-blockers (selective and non-selective) demonstrated adverse effects on blood lipids.
- Antihypertensives including beta-blockers with intrinsic sympathomimetic activity, labetalol, methyldopa, calcium channel blockers, and ACE-inhibitors were found to be lipid neutral.
- Alpha-adrenergic blockers appeared to have a beneficial effect on lipid metabolism.
Conclusions:
- Conventional antihypertensive therapies (diuretics, beta-blockers) may negatively influence lipid profiles, potentially explaining their failure to prevent CHD.
- Certain antihypertensives (ACE-inhibitors, calcium channel blockers, alpha-blockers) exhibit neutral or favorable lipid profiles.
- Further controlled clinical trials are necessary to confirm the long-term clinical significance of antihypertensives with neutral or favorable lipid effects.
Abstract:
Despite the well-established correlation between coronary heart disease (CHD) and hypertension, conventional antihypertensive therapy with diuretics and beta-adrenergic blockers has failed to provide protection against CHD. A possible explanation for this failure is the unfavourable effect such drugs have on lipid metabolism. To compare the lipid profiles of commonly used antihypertensive drugs, a survey was made of selected studies from the literature. Diuretics and selective and nonselective beta-blockers were found to have adverse effects on blood lipids. Beta-blockers with intrinsic sympathomimetic activity, labetalol, methyldopa, calcium channel blockers and ACE-inhibitors are lipid neutral, whereas alpha-adrenergic blockers seemed to have a favourable effect on lipid metabolism. Controlled clinical trials with drugs that have no adverse effects on lipid metabolism are needed to establish the long-term clinical importance of such agents.